Gaylord Chemical Company, LLC Rebrands to gChem: Success is One Molecule Away
Covington, Louisiana – April 7, 2025 – As a reflection of its ongoing evolution, Gaylord Chemical Company, LLC, a leader in the chemical industry, is proud to unveil its new brand identity: gChem.
Since 1960, Gaylord has proudly led the way as the world’s premier provider of premium Dimethyl Sulfoxide (DMSO) for customers globally. Headquartered in Covington, Louisiana, with state-of-the-art manufacturing facilities in Tuscaloosa, Alabama, gChem is dedicated to upholding the highest standards of safety, efficacy, and sustainability.
The new brand reflects gChem’s ambition to drive scientific innovation in the development and production of DMSO solutions for pharmaceuticals, agriculture, micro-electronic and other global industries.
“At gChem, our mission is to be the champion of DMSO for the benefit of our partners, the industry and the world at large,” said Frank Roederer, CEO of gChem. “We are leading the way in a new era of DMSO by providing chemistry with a conscience and delivering innovation that meets the evolving needs of our customers.”
gChem, is committed to fostering a culture of scientific curiosity and innovation, ensuring that our products and services continue to set the benchmark for quality and reliability in the chemical industry. Additionally, the rebranding signifies a renewed focus on attracting the industry’s best talent to ensure continued excellence in all aspects of our operations.
For more information, please visit our website at www.gchemglobal.com or contact Debbie Barnewold, HR Leader, at dbarnewold@gchemglobal.com.
About gChem
gChem, formerly Gaylord Chemical, is a leading provider of DMSO-based solutions. With headquarters in Covington, Louisiana, and manufacturing facilities in Tuscaloosa, Alabama, gChem is dedicated to driving scientific innovation, upholding the highest standards of safety and sustainability, and attracting top talent to ensure continued excellence.
Gaylord Chemical Company and iFormulate Host Thought-Provoking Webinar Taking a Fresh Look at Agrochemical Solvents: “Change, Change, Change – A New Option for Liquid Agrochemical Reformulation”
Gaylord Chemical Company, L.L.C., in collaboration with iFormulate, announces the webinar “Change, Change, Change – A New Option for Liquid Agrochemical Reformulation,” taking place on February 25, 2025, at 3 PM CET | 9 AM EST | 8 AM CST |6 AM PST | 2 PM UK.
This highly timely event will provide professionals in the agrochemical sector with the latest insights into regulatory changes, solvent innovations, and strategic approaches to meet new challenges head-on.
This 45-minute to 1-hour session is tailored to help attendees navigate the rapidly shifting landscape of agrochemical solvents, featuring in-depth discussions on recent Environmental Protection Agency (EPA) updates concerning Dimethylsulfoxide (DMSO) and imminent restrictions on N-methylpyrrolidone (NMP). As the industry braces for these regulatory shifts, the webinar will showcase DMSO as the go-to solvent for its regulatory approval, availability, cost benefits, and superior formulation flexibility.
Attendees will gain:
- Expert insights: Receive valuable guidance from renowned industry experts,
including Dr. David Calvert and Dr. Jim Bullock of iFormulate, alongside Mick
Sadoudi and Dr. Artie McKim from Gaylord Chemical Company. - Regulatory updates: Stay ahead with the latest regulatory changes and understand
their practical implications on your formulations. - Practical solutions: Discover how DMSO can effectively address the regulatory
hurdles posed by the impending NMP restrictions, helping you innovate and
maintain compliance.
Dr. David Calvert, Director and co-founder of iFormulate, will kick off the session by
exploring the critical role of solvents in agrochemical formulations. “Our aim is to equip
attendees with the knowledge they need to adapt to regulatory shifts and to offer
practical tools for solvent selection,” shares Dr. Calvert.
Dr. Artie McKim, Vice President of Technology at Gaylord Chemical Company, adds, “With the looming restrictions on NMP, we’re eager to demonstrate how DMSO can revolutionize the industry, providing a safer, more efficient alternative that meets both regulatory and formulation needs.”
To join, register here. Questions can be submitted ahead of time to Carmen Tizapa-Zamora (czamora@gaylordchem.com) or asked during the Q&A session at the end of the webinar. A recording and the presentation deck will be available to all attendees after the event.
END OF RELEASE
Media contact:
Brandon Shaw
Global Director of Marketing at Gaylord Chemical Company
bshaw@gaylordchem.com
Corporate Office: 800.426.6620
☆ Exciting Milestone Achieved at Gaylord Chemical! ☆
November 19th, 2024
We are delighted to announce the successful expansion of our plant’s capacity, a pivotal milestone in our ongoing commitment to innovation, sustainability, and growth. This expansion will enhance our ability to continue serving customers with our high standards of producing sustainable and safer products.
On October 18, we had the honor of hosting a special event to celebrate this achievement. We were privileged to welcome esteemed guests, including representatives from the West Alabama Chamber of Commerce, the Mayor of Tuscaloosa, and representatives from the offices of Senator Katie Britt and Senator Tommy Tuberville. Our CEO Frank Roederer led the event, sharing insights into this significant development and our future vision.
The event highlighted our dedication to excellence and our investment in the community and local economy. We are excited about the opportunities this expansion brings and look forward to continuing our journey of growth, innovation, and sustainability. A heartfelt thank you to all our guests and partners who joined us in celebrating this exciting new chapter for Gaylord Chemical!
Understanding the Value of Excipient Grade in Pharmaceutical Development
October 18th, 2024
At Gaylord Chemical Company, we recognize that excipients are not just passive ingredients; they play a crucial role in the efficacy and safety of drug products. Dr. Nigel Langley, our Global Technical Director, recently highlighted the significance of understanding excipient grades during a panel discussion with Pharmaceutical Technology. As emphasized by Dr. Langley and other industry experts, the correct choice of excipient is vital to ensure patient safety and product reliability.
Excipients often constitute the majority of drug formulations, serving essential functions such as modifying the release of active pharmaceutical ingredients (APIs), enhancing stability, and improving patient compliance. However, the importance ofexcipient grade and quality is sometimes overlooked, leading to potentially severe consequences for patient safety.
The FDA defines an excipient as a drug component that must meet stringent Good Manufacturing Practices (GMP) and comply with relevant pharmacopeia standards. In an increasingly global market, manufacturers must navigate various regulatory landscapes, from the United States Pharmacopeia (USP) to the European Pharmacopoeia (Ph.Eur.). At Gaylord Chemical, we prioritize compliance and quality in our excipient products to meet the diverse needs of our clients.
Dr. Langley pointed out that there has historically been a tendency to treat excipients as commodities, leading to miscommunications between suppliers and users. Effective collaboration and understanding of supply chains are critical in selecting the right excipient grade. We advocate for open communication with our clients to ensure the materials we provide align with their specific applications and regulatory requirements.
Traceability within the excipient supply chain cannot be overstated. As highlighted in the panel discussion, the lack of traceability has led to instances of using incorrect or counterfeit materials. Our commitment to traceability allows us to guarantee the
integrity of our products from the point of manufacture to their use in drug development.
To ensure safety and efficacy, it is crucial to qualify excipient suppliers and understand the functional characteristics of materials used in formulations. With Procipient®, our innovative DMSO excipient, we are dedicated to providing pharmaceutical manufacturers with high-quality materials that have been produced under stringent GMP conditions. This ensures our products consistently meet the necessary specifications for their intended use.
Collaboration between excipient manufacturers and pharmaceutical developers is essential for advancing drug development and ensuring patient safety. Gaylord Chemical is committed to fostering these partnerships to enhance the quality of pharmaceutical products.
For more insights, read the full article by Felicity Thomas in Pharmaceutical Technology Europe here (pages 13-15 on the PDF). If you have any questions about Gaylord Chemical or Procipient®, please don’t hesitate to get in touch with our team for more information, or scan the QR code on page 36 of the PDF.
Gaylord Chemical’s New AgXalt™ Series – Designed and Tested for use in Regulated Agrichemical Applications
June 20th , 2023
Gaylord Chemical Company is proud to announce the launch of AgXalt™ X-100, a safe yet powerful solvent specifically designed and tested for use in regulated agrichemical applications. AgXalt™ X-100 is the culmination of many years of testing and collaboration with regulators to put a safe and highly effective solvent into the hands of ag formulators globally.
In a regulatory climate in which chemical products are evaluated under considerable scrutiny, it is no small task to gain approvals for a new end-use application in agriculture. AgXalt™ X-100’s recent EPA decision regarding its standing under 40 CFR § 180.920 is a true testament to its safety profile and its performance has been clearly demonstrated.
Gaylord develops products that are optimized to meet the needs of highly specialized end-use applications with considerable performance and regulatory requirements and AgXalt™ X-100 is no exception. This product has a safety, regulatory, and performance profile that is unmatched by any solvent in the industry. Importantly, Gaylord has made considerable investments to ensure reliable domestic supply of AgXalt™ X-100 in order to support its large-scale use in Ag. In addition to 100% domestic production, Gaylord is proud to be backward integrated and 100% US sourced for every single raw material used to make AgXalt™ X-100.
This is a proud moment for Gaylord Chemical! We look forward to helping our customers innovate for the future.
World’s first dedicated Nitrogen Tetroxide (N2O4) Facility Completed
February 15th, 2023
Gaylord Chemical Company is proud to announce the successful back-integration into all critical raw materials with the completion of the world’s first dedicated Nitrogen Tetroxide (N2O4) production facility which is located in Tuscaloosa, USA. With this major achievement, Gaylord Chemical Company has full control of the availability and quality of the entire value chain from basic to specialty chemicals.
This substantial investment allows us to serve our DMSO customers with significantly improved product availability and thus considerably greater security of supply. We are the only DMSO producer worldwide that is fully back integrated into N2O4, and is able to control quality and availability from the cradle to grave.
Gaylord Chemical Company employees are to be commended for their work and diligence to develop and build the first and only on-purpose Nitrogen Tetroxide production plant in the world, capable of producing the highest purity N2O4 grades. This is a proud moment for Gaylord Chemical to announce this most recent company achievement which once again demonstrates our commitment as the preeminent producer of DMSO globally.
